Clinical Trial Update: Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial results evaluating Pentoxifylline for reducing proteinuria in Korean patients with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2017-06-16